Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Inj. insulin degludec with insulin aspart

Insuline degludec inj 100iu/ml prefilled pen

Inj. insulin degludec 100 i.u.

Inj insulin - human mixtard 70/30 100 iu/10 ml

Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

(ph no.:10013) human insulin mix.of 30/70 (rdna origin) 40 iu/ml - 10 ml inj.

Inj tirzepatide 2.5 mg,inj tirzepatide 5 mg,inj tirzepatide7. 5 mg,inj tirzepatide 10 mg,tab acalabrutinib 100 mg,tab niraparib 100 mg,inj insulin aspart analogue rapid acting 100 iuperml 3 ml pfs,inj tislelizumab 100 mg 10 ml vial

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.